Email
Print
23-Valent Pneumococcal Polysaccharide Vaccine Market - Forecast(2024 - 2030)
1. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Overview
1.1 Definitions and Scope
2. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. 23-Valent Pneumococcal Polysaccharide Vaccine Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. 23-Valent Pneumococcal Polysaccharide Vaccine Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. 23-Valent Pneumococcal Polysaccharide Vaccine Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Age-Group (Market Size -$Million / $Billion)
8.1 Child
8.2 Adult
8.3 Geriatrics
9. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Dose Type (Market Size -$Million / $Billion)
9.1 Single Dose Vial
9.2 Pre-Filled Syringe
10. 23-Valent Pneumococcal Polysaccharide Vaccine - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. 23-Valent Pneumococcal Polysaccharide Vaccine- By Geography (Market Size -$Million / $Billion)
11.1 23-Valent Pneumococcal Polysaccharide Vaccine Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 23-Valent Pneumococcal Polysaccharide Vaccine- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 23-Valent Pneumococcal Polysaccharide Vaccine- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 23-Valent Pneumococcal Polysaccharide Vaccine - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 23-Valent Pneumococcal Polysaccharide Vaccine - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Key Company List by Country Premium
15. 23-Valent Pneumococcal Polysaccharide Vaccine Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astrazeneca
15.3 Baxter International Inc
15.4 Beijing Minhai Biotechnology
15.5 Biogen Inc
15.6 Eli Lilly And Company
15.7 Glaxosmithkline Plc
15.8 Merck Co
15.9 Pfizer Inc
15.10 Sanofi S A
15.11 Serum Institute Of India
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. 23-Valent Pneumococcal Polysaccharide Vaccine Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. 23-Valent Pneumococcal Polysaccharide Vaccine Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. 23-Valent Pneumococcal Polysaccharide Vaccine Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Age-Group (Market Size -$Million / $Billion)
8.1 Child
8.2 Adult
8.3 Geriatrics
9. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Dose Type (Market Size -$Million / $Billion)
9.1 Single Dose Vial
9.2 Pre-Filled Syringe
10. 23-Valent Pneumococcal Polysaccharide Vaccine - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. 23-Valent Pneumococcal Polysaccharide Vaccine- By Geography (Market Size -$Million / $Billion)
11.1 23-Valent Pneumococcal Polysaccharide Vaccine Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 23-Valent Pneumococcal Polysaccharide Vaccine- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 23-Valent Pneumococcal Polysaccharide Vaccine- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 23-Valent Pneumococcal Polysaccharide Vaccine - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 23-Valent Pneumococcal Polysaccharide Vaccine - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Key Company List by Country Premium
15. 23-Valent Pneumococcal Polysaccharide Vaccine Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astrazeneca
15.3 Baxter International Inc
15.4 Beijing Minhai Biotechnology
15.5 Biogen Inc
15.6 Eli Lilly And Company
15.7 Glaxosmithkline Plc
15.8 Merck Co
15.9 Pfizer Inc
15.10 Sanofi S A
15.11 Serum Institute Of India
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Appendix16.1 Abbreviations
16.2 Sources
17. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 ($M)1.1 Single Dose Vial Market 2019-2024 ($M) - Global Industry Research
1.2 Pre-Filled Syringe Market 2019-2024 ($M) - Global Industry Research
2.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 ($M)
2.1 Child Market 2019-2024 ($M) - Global Industry Research
2.2 Adult Market 2019-2024 ($M) - Global Industry Research
2.3 Geriatrics Market 2019-2024 ($M) - Global Industry Research
3.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 (Volume/Units)
3.1 Single Dose Vial Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Pre-Filled Syringe Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 (Volume/Units)
4.1 Child Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Adult Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Geriatrics Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 ($M)
5.1 Single Dose Vial Market 2019-2024 ($M) - Regional Industry Research
5.2 Pre-Filled Syringe Market 2019-2024 ($M) - Regional Industry Research
6.North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 ($M)
6.1 Child Market 2019-2024 ($M) - Regional Industry Research
6.2 Adult Market 2019-2024 ($M) - Regional Industry Research
6.3 Geriatrics Market 2019-2024 ($M) - Regional Industry Research
7.South America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 ($M)
7.1 Single Dose Vial Market 2019-2024 ($M) - Regional Industry Research
7.2 Pre-Filled Syringe Market 2019-2024 ($M) - Regional Industry Research
8.South America 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 ($M)
8.1 Child Market 2019-2024 ($M) - Regional Industry Research
8.2 Adult Market 2019-2024 ($M) - Regional Industry Research
8.3 Geriatrics Market 2019-2024 ($M) - Regional Industry Research
9.Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 ($M)
9.1 Single Dose Vial Market 2019-2024 ($M) - Regional Industry Research
9.2 Pre-Filled Syringe Market 2019-2024 ($M) - Regional Industry Research
10.Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 ($M)
10.1 Child Market 2019-2024 ($M) - Regional Industry Research
10.2 Adult Market 2019-2024 ($M) - Regional Industry Research
10.3 Geriatrics Market 2019-2024 ($M) - Regional Industry Research
11.APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 ($M)
11.1 Single Dose Vial Market 2019-2024 ($M) - Regional Industry Research
11.2 Pre-Filled Syringe Market 2019-2024 ($M) - Regional Industry Research
12.APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 ($M)
12.1 Child Market 2019-2024 ($M) - Regional Industry Research
12.2 Adult Market 2019-2024 ($M) - Regional Industry Research
12.3 Geriatrics Market 2019-2024 ($M) - Regional Industry Research
13.MENA 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Dose Type Market 2019-2024 ($M)
13.1 Single Dose Vial Market 2019-2024 ($M) - Regional Industry Research
13.2 Pre-Filled Syringe Market 2019-2024 ($M) - Regional Industry Research
14.MENA 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Age-Group Market 2019-2024 ($M)
14.1 Child Market 2019-2024 ($M) - Regional Industry Research
14.2 Adult Market 2019-2024 ($M) - Regional Industry Research
14.3 Geriatrics Market 2019-2024 ($M) - Regional Industry Research
LIST OF FIGURES
1.US 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)2.Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
3.Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
4.Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
5.Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
6.Peru 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
7.Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
8.Chile 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
9.Rest of South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
10.UK 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
11.Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
12.France 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
13.Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
14.Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
15.Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
16.China 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
17.India 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
18.Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
19.South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
20.South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2019-2024 ($M)
21.North America 23-Valent Pneumococcal Polysaccharide Vaccine By Application
22.South America 23-Valent Pneumococcal Polysaccharide Vaccine By Application
23.Europe 23-Valent Pneumococcal Polysaccharide Vaccine By Application
24.APAC 23-Valent Pneumococcal Polysaccharide Vaccine By Application
25.MENA 23-Valent Pneumococcal Polysaccharide Vaccine By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Merck Co, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Baxter International Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Beijing Minhai Biotechnology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Serum Institute Of India, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Biogen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)